WeedMD Inc. (TSX-V:WMD), a federally licensed producer and distributor of medical cannabis, is pleased to announce that it has signed agreements to supply medicinal cannabis products on an exclusive basis with three long-term care (“LTC”) and retirement home providers. These include peopleCare CommunitiesArbour Heights, and the Belmont Long Term Care Facility, which together total nine homes with more than 1,000 beds across Ontario.

“As the first Canadian licensed producer to sign multiple supply contracts for senior resident care, we are beginning to validate our long-standing strategy. We are leveraging our teams’ four decades of experience in the LTC and seniors’ industry to secure these initial exclusive supply agreements, accelerating our plan of becoming Canada’s partner of choice for LTC and retirement home providers,” said Bruce Dawson-Scully, CEO of WeedMD. “Being chosen as the exclusive cannabis provider to these communities highlights our ability to provide medicinal cannabis products in conjunction with our integrated priority program developed for the long-term care, assisted living, and seniors’ markets. We see these contracts as just the beginning and will continue to focus on expanding the seniors’ market by providing access to alternative health care solutions and building our business.”


“We are excited to be working with WeedMD in offering alternative health care solutions for our valued residents as we look to provide safe, cutting edge, innovative and sustainable ways to enhance their quality of care. We are equally proud to be among the first cohort of Canadian LTC facilities to formally sponsor the use of medical cannabis,” said Andrea Brissette, Vice President, Care and Services at peopleCare Communities. “WeedMD’s high regard for excellent patient support aligns perfectly with peopleCare’s core principles as we establish policies and education programs to properly roll out our medical cannabis program. We look forward to building on this partnership in the years to come.”
With a demographic that is growing at four times the rate of the broader population, the Company views the long-term care, assisted living and seniors’ market as one of the most attractive medical markets. Seniors carry a large pharmaceutical burden and a sizeable portion of the population is living in, or seeking, assisted living facilities. WeedMD forecasts that patients in this segment can generate upwards of three times the lifetime value (LTV) of a typical patient under the Access to Cannabis for Medical Purposes Regulations (ACMPR), generated by higher, more consistent consumption and a more operationally efficient patient acquisition and distribution model.
In addition to peopleCare Communities and its more than 750 beds, the Company also signed respective agreements with Arbour Heights and its sister home, the Belmont Long Term Care Facility, which together house more than 300 beds. These programs are expected to be rolled out before year-end, following the soon-to-be expected receipt of the Company’s license to sell cannabis oil – as its production license was received on June 19, 2017. In what represents a significant milestone for the medical cannabis and long-term care industries, WeedMD will be the exclusive supplier of cannabis products for distribution to the residents of these communities.
The Company will continue to focus on securing additional supply contracts in the long-term care, assisted living and seniors’ markets offering its proprietary integrated care program along with its cannabis products. Also, WeedMD is advancing a very compelling expansion plan to position itself strategically for the future adult-use market which it expects to unveil in the coming weeks.
For more information, access our investor presentation on our website here.
About WeedMD Inc.
WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer and distributor of medical cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). The Company operates a 26,000 sq. ft. indoor facility in Aylmer, ON, with four acres of property for future expansion. The Company has entered into strategic relationships with established cannabis brands, including leading, premium, female-focused Van der Pop. WeedMD is focused on providing consistent, quality medicine to the long-term care, assisted living and seniors’ markets in Canada through its specialized, comprehensive platform, and is dedicated to educating healthcare practitioners and furthering the public understanding of medical cannabis as a viable alternative to prescription medication – relieving a variety of chronic medical conditions and illnesses.
About peopleCare Communities
peopleCare Communities is an industry leader in South Western Ontario.  Three generations have honoured a philosophy of care and a passion for service.  This continues today by embracing new and best practices in senior living with the commitment to make each peopleCare residence a place where seniors are treated with dignity and respect.  Headquartered in Kitchener, Ontario, peopleCare Communities owns and manages seven long term care homes.  The first retirement home will be opening in London, Ontario in October 2017.
Follow WeedMD On:
Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://www.linkedin.com/company-beta/5020743/
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/
For further information, please contact:
WeedMD Inc.
Keith Merker, Chief Financial Officer
Tel: 519-765-2440 Ext. 222
Email: investor@weedmd.com

To learn more, visit us at www.weedmd.com

For Media Inquiries:

Marianella delaBarrera
Margin Communications & Public Relations
Tel: 416-897-6644
Email: marianella@marginpr.com

Forward-Looking Information

This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Company’s common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE

Source: globenewswire.com

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less